ReNeuron Group plc

ReNeuron Group plc

ReNeuron wants to renew damaged brain cells with stem cell therapy. Founded in 1997 by leading scientists at the London-based Institute of Psychiatry, the company is researching the feasibility of transplanting stem cells into patients with Parkinson's disease, Huntington's disease, type 1 diabetes, stroke, and other neurological disorders. ReNeuron also is studying the possible use of stem cells to treat brain tumors and in non-therapeutic areas with its ReNcell drug development platform. Investors include Merlin Ventures, a leading UK biotechnology investor.

Contact Details

Office Address

ReNeuron Group plc
10 Nugent Rd., Surrey Research Park
Guildford, Surrey, UK GU27AF
Phone: +44-1483-302-560
Fax: +44-1483-534-864

Executives

CEO and Director

Michael E. Hunt

Business Reviews for ReNeuron Group plc

Related Companies